Nitric oxide as a carcinogen: Analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 379, Issue 2, 1997, Pages 211-218

  Murata, Jun Ichi ^a   Tada, Mitsuhiro ^a   Iggo, Richard D ^b   Sawamura, Yutaka ^a   Shinohe, Yumiko ^a   Abe, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Deamination; Mutation; Nitric oxide; p53 tumor suppressor; Yeast functional assay

Indexed keywords

CARCINOGEN; NITRIC OXIDE; PROTEIN P53;

ARTICLE; DEAMINATION; METHYLATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; YEAST;

CARCINOGENS; CYTOSINE; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; GENES, P53; GUANINE; HUMANS; MUTAGENESIS; MUTAGENICITY TESTS; NITRIC OXIDE; POINT MUTATION; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC); SYDNONES; YEASTS;

EID: 0031556534     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00149-8     Document Type: Article

References (30)

1. Farias-Eisner R., Sherman M.P., Aeberhard E., Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;9407-9411.
2. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
3. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;3030-3034.
4. Bartsch H., Ohshima H., Pignatelli B., Calmels S. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics. 2:1992;272-277.
5. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Res. 305:1994;253-264.
6. de Rojas-Walker T., Tamir S., Ji H., Wishnok J.S., Tannenbaum S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem. Res. Toxicol. 8:1995;473-477.
7. Lewis R.S., Tamir S., Tannenbaum S.R., Deen W.M. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J. Biol. Chem. 270:1995;29350-29355.
8. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
9. Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1993;1318-1327.
10. S. Friend, 1994.
11. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hovig E., Montesano R., Harris C.C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res. 24:1996;141-146.
12. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 265:1994;346-355.
13. Duncan B.K., Miller J.H. Mutagenic deamination of cytosine residues in DNA. Nature. 287:1980;560-561.
14. Coulondre C., Miller J.H., Farabaugh P.J., Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature. 274:1978;775-780.
15. Cooper D.N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78:1988;151-155.
16. Routledge M.N., Wink D.A., Keefer L.K., Dipple A. Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E. coli MBM7070 cells. Carcinogenesis. 14:1993;1251-1254.
17. Loeb L.A., Preston B.D. Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 20:1986;201-230.
18. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 362:1993;709-715.
19. Yebra M.J., Bhagwat A.S. A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine. Biochemistry. 34:1995;14752-14757.
20. Schmutte C., Yang A.S., Nguyen T.T., Beart R.W., Jones P.A. Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res. 56:1996;2375-2381.
21. Flaman J.-M., Frebourg T., Moreau V., Charbonnier F., Martin C., Chappuis P., Sappino A.-P., Limacher J.-M., Brons L., Benhattar J., Tada M., Van Meir E.G., Estreicher A., Iggo R.D. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. USA. 92:1995;3963-3967.
22. Tada M., Iggo R.D., Ishii N., Shinohe Y., Sakuma S., Estreicher A., Sawamura Y., Abe H. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay. Int. J. Cancer. 67:1996;447-450.
23. Feelisch M., Ostrowski J., Noack E. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14(Suppl. 11):1989;S13-S22.
24. Schrör K., Förster S., Woditsch I., Schröder H. Generation of NO from molsidomine (SIN-1) in vitro and its relationship to changes in coronary vessel tone. J. Cardiovasc. Pharmacol. 14(Suppl. 11):1989;S29-S34.
25. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
26. Darley U.V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 369:1995;131-135.
27. Ho Y.S., Wang Y.J., Lin J.K. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinogen. 16:1996;20-31.
28. Forrester K., Ambs S., Lupold S.E., Kapust R.B., Spillare E.A., Weinberg W.C., Felley B.E., Wang X.W., Geller D.A., Tzeng E., Billiar T.R., Harris C.C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA. 93:1996;2442-2447.
29. Murata J., Corradin S.B., Janzer R.C., Juillerat J.L. Tumor cells suppress cytokine-induced nitric-oxide (NO) production in cerebral endothelial cells. Int. J. Cancer. 59:1994;699-705.
30. Tornaletti S., Pfeifer G.P. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene. 10:1995;1493-1499.